Figure 4 - available via license: Creative Commons Attribution-NonCommercial 3.0 Unported
Content may be subject to copyright.
Source publication
Purpose: To report two cases of conjunctival mucosa-associated lymphoid tissue (MALT) lymphomas treated with cryotherapy. Case summary: Two patients with MALT lymphoma of the conjunctiva were treated by carbon dioxide cryotherapy under topical anesthesia using 0.5% proparacaine hydrochloride (Alcaine®, Alcon). Cryotherapy was repeated in recurrent...
Citations
... It has been reported that more than 90% of such lesions do not go on to develop into systemic lymphoma [1]. There is no definitive recommended treatment for conjunctival BLH, but reported treatments include cryotherapy and the combination of surgical excision and oral steroid administration [2,3]. There have also been reports of using local radiotherapy to prevent malignant proliferation and systemic invasion [4]. ...
We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization.
To report a single case of Rosai-Dorfman disease of the palpebral conjunctiva with a review of the relevant literature.
